4-Hydroxylation of estrogens as marker of human mammary tumors.
about
Molecular details of cAMP generation in mammalian cells: a tale of two systemsMetabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissueCatechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young womenEstrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathwayMolecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiatorsExpression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesisRethinking breast cancer risk and the environment: the case for the precautionary principleTetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibromaEstrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female miceDietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers.Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.Dioxin and endometrial progesterone resistanceEarly changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsCardiovascular protective effects of 17beta-estradiol metabolites.Tracking progesterone receptor-mediated actions in breast cancerCytochrome P450 family 1 inhibitors and structure-activity relationships.Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit womenReactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cellsHormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters.Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancerCritical role of oxidative stress in estrogen-induced carcinogenesis.Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants.Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors.Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved.Estrogen metabolism and breast cancer.Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters.Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate.Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells.Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs.Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovariesA novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.Cellular iron metabolism in prognosis and therapy of breast cancer.Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study.Estrogen receptor α can selectively repress dioxin receptor-mediated gene expression by targeting DNA methylation
P2860
Q24622606-E14C1466-2F29-4BA0-9F08-393B13B1AD3CQ24796091-722C5785-EDB4-462F-B7B7-2742ECF39070Q28214188-8A0B1013-CA1E-4EAC-8B7A-92082C016752Q28352494-AE9FA9F6-E2B3-4B73-BAE5-87DB29834ED7Q28379238-09A6F23A-7FAE-46AC-AA33-4C4EE9D387D0Q28645872-B973A413-A204-40E0-822A-7B102B521B1AQ28645937-06996478-D8EE-49DF-A849-C5B44390D0B8Q28768205-4926B9F5-F617-4250-B3F8-2A1D315DE130Q30393970-00414F2E-6A54-4153-BA27-4784F21F81B2Q30440774-56022D1B-E283-44D4-B328-EA75496E7A85Q33468680-BF000C8B-AFAF-4E43-B1B2-B24BF34698C0Q33781116-D896FA6B-BAA2-4461-974E-D22484A5BBFDQ33787147-ABCBDEDE-2A19-4155-8807-2B3ECC0BAED7Q33789686-8124CD16-0178-43D8-97A5-A97BE0726B39Q33834356-4594A7A4-B617-4F66-99C6-2D76EB986567Q33874669-F78A6AF2-1FDC-4BFE-BA27-590818C4793EQ33958919-7CD52DA8-546E-4FE9-B4E9-68CD08A8EB52Q34148850-41E398CC-11F1-4A18-8C92-A5868597AD89Q34377353-64F3D048-ECFB-4BA2-9E97-93E562588908Q34388848-C78EA475-5074-4D45-8999-532151555384Q34436975-F07C4C71-C7CF-4EC4-89EC-01EE22ED8979Q34524819-87DF1D90-2B14-431A-80BF-197FADC980E0Q34598054-FBE69A4B-CBDD-474B-9C6B-286A99CF48A7Q34638087-BDA23732-20E9-4BB2-8E74-48C840262E40Q34638169-C7B56AB2-B1F2-4DCF-BEF7-DB49F261CC89Q34918773-175B97CC-B655-4BAA-B19C-C85708B2B13AQ34983069-BEFDEB21-6302-404B-8CAB-5B3438FD2CC5Q35072792-F5D2F772-FA1F-43CA-91D6-9BD3FCCB2989Q35533921-7FA6AAF2-6566-4F3F-9D86-F8D1327D3192Q35861660-A5750627-616B-4CEE-8097-44C71EAD3E72Q35956173-A0D60323-A932-4BBC-91B8-B82843137104Q36107447-522FF12A-FFF5-4F98-842C-8C4F4673F4B2Q36128919-B819B394-9BEB-4F69-B68C-C939705D9BD6Q36264616-1536B6ED-9E25-4FE0-8569-F2ED8E01F0D1Q36322483-67FF1F70-FB8C-48A2-93A4-680CF78A5651Q36767559-422F920E-A881-49ED-9854-D629CB4ED24CQ36833617-B5358479-1BFB-4434-9458-FCA645CFC7B3Q37077422-FB6CD8FE-F7B9-4604-AB01-484CDD20DA51Q37089458-B1EA92D1-4973-48D8-B1F5-F6A05D2EAB6DQ37197814-AB107125-B448-4392-A2D7-161ACBE13D07
P2860
4-Hydroxylation of estrogens as marker of human mammary tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
4-Hydroxylation of estrogens as marker of human mammary tumors.
@en
4-Hydroxylation of estrogens as marker of human mammary tumors.
@nl
type
label
4-Hydroxylation of estrogens as marker of human mammary tumors.
@en
4-Hydroxylation of estrogens as marker of human mammary tumors.
@nl
prefLabel
4-Hydroxylation of estrogens as marker of human mammary tumors.
@en
4-Hydroxylation of estrogens as marker of human mammary tumors.
@nl
P2860
P356
P1476
4-Hydroxylation of estrogens as marker of human mammary tumors.
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.8.3294
P407
P577
1996-04-01T00:00:00Z